ELDN Latest Press Releases

-- October 26, 2026 --

Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting Globe Newswire 7:00 AM

-- October 5, 2026 --

Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting Globe Newswire 4:05 PM

-- September 22, 2026 --

Eledon Presents Updated Long-Term Phase 2 BESTOW Extension Study Results at the International Congress of The Transplantation Society Globe Newswire 7:00 AM

-- September 9, 2026 --

Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society Globe Newswire 7:00 AM

-- September 3, 2026 --

Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026 Globe Newswire 7:00 AM

-- August 13, 2026 --

Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 4:05 PM

-- July 8, 2026 --

The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy PRNewswire 9:01 AM

-- July 1, 2026 --

NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes Globe Newswire 9:30 AM

-- June 25, 2026 --

Natera and Eledon Announce Strategic Partnership for Prospera Monitoring in Planned Phase 3 Kidney Transplant Trial Business Wire 7:00 AM

-- June 22, 2026 --

Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus Globe Newswire 7:00 AM

-- June 8, 2026 --

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes